Comparing Ticagrelor Versus Clopidogrel in Patients With a History of Cerebrovascular Disease A Net Clinical Harm?

Stroke

Volumn 43, Issue 12, 2012, Pages 3409-3410

  Di Nicolantonio, James J ^a   Serebruany, Victor L ^b  

^a Wegmans Pharmacy   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Carotid disease; Cerebrovascular disease; Clopidogrel; Intracranial hemorrhage; Stroke; Ticagrelor; Transient ischemic attack; Vertebrobasilar disease

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DRUG FATALITY; HAZARD RATIO; HEART INFARCTION; HUMAN; HUNGARY; LENGTH OF STAY; LOADING DRUG DOSE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POLAND; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE; UNITED STATES;

ADENOSINE; CEREBROVASCULAR DISORDERS; HUMANS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RISK FACTORS; TICLOPIDINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84870868303     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.668988     Document Type: Review

References (6)

1. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
2. US Food and Drug Administration. The FDA ticagrelor review of complete response. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/nda/2011/ 022433Orig1s000TOC.cfm. Accessed May 10, 2012.
3. James SK, Storey RF, Khurmi NS, Husted S, Keltai M, Mahaffey KW, Maya J, Morais J, Lopes RD, Nicolau JC, Pais P, Raev D, Lopez-Sendon JL, Stevens SR, Becker RC; PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack. Circulation. 2012;125:2914-2921.
4. Verheugt FW. Beware of novel antiplatelet therapy in acute coronary syndrome patients with previous stroke. Circulation. 2012;125:2821-2823.
5. Serebruany VL. Viewpoint: paradoxical excess mortality in the PLATO trial should be independently verified. Thromb Haemost. 2011;105:752-759.
6. The IST-3 Collaborative Group.The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012, 379:2352-2363.